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Abstract:  
Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use 
the produced insulin. Morinda citrifolia has been widely used as herbal medicine to  prevent and to  treat diabetes as well as health 
supplements. It contains flavonoids which may act as an antidiabetic agent. One of the receptors that play a role in the treatment of diabetes 
is peroxisome proliferator-activated receptor - gamma (PPARγ) which responsible for insulin sensitization in adipose tissue. In this study, the 
interaction beetween flavonoids contained in  noni fruit as ligands, and PPARγ was investigated by using the Autodock Vina software. Some 
flavonoids such as quercetin, kaempferol, nicotifloroside, narcissoside, and rutin were included in this study. Rosiglitazone, a known ligand 
for PPARγ was used as the standard. The result revealed that all the selected flavonoids showed binding energy ranging between –8,1 
kcal/mol to  –8,5 kcal/mol. Eventhough, when compared with rosiglitazone (–8.9 kcal/mol), the value of the binding energy of flavonoids 
was higher, but close to rosiglitazone. This suggests that those flavonoid compounds may show comparable potential with rosiglitazone as 
antidiabetic agent. 
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Introduction  
Diabetes is a chronic disease that occurs either when the 
pancreas does not produce enough insulin or when the 
body cannot effectively use the insulin it produces. Data 
from WHO in 2013 showed that 347 million people 
worldwide suffer from diabetes. Indonesia is the 7th 
country with the highest number of diabetics in the 
world. By 2030, the estimated population of diabetics in 
Indonesia reached 11.8 million, with the growth 
percentage of 6% per year which far exceeds the growth 
of overall Indonesia's population [1]. 
 
PPARγ plays a role in insulin sensitization process, and 
is used as a therapeutic target of type 2 diabetes mellitus. 
Thiazolidinediones is a class of antidiabetic agent works 
by binding to PPARγ, thereby increasing insulin 
stimulation by glucose transporter receptor 4 (GLUT4) 
and glycogen synthesis which leads to increased insulin 
signaling and insulin sensitivity [2].  
 
Morinda citrifolia, or noni fruit commonly called 
pace/noni, had been widely used by the public as 
prevention and treatment of diabetes as well as health 
supplements. Several previous studies stating that 
Morinda citrifolia contains approximately 200 chemical 
compounds which have been identified and isolated from 
various parts of this plant. One of them is a flavonoid 
compound found in the fruit, flowers, and leaves [3]. 
 
The ethanol extract of Morinda citrifolia can lower 
blood sugar levels due to antioxidant activity of 
flavonoid contained in the plant [4].  Quersetin can 
regenerate the pancreas and may increase the release of 
insulin in diabetic rats induced by streptozotosin [5]. In 
the meantime, the flavonoid compounds found in Citrus 
sp. [6] by the method of molecular docking, and resulted 
in a statement that the flavonoid compounds have good 
docking results on several protein targets related to 
diabetes, such as Peroxisome Proliferator-Activated 
Receptor-Gamma (PPARγ) which responsible for insulin 
sensitization on the adipose tissue. 
 
In this research, some flavonoids of Noni Fruit (Morinda 
citrifolia), including quercetin, kaempferol, 
nicotifloroside, narcissoside, and rutin as ligands for 
PPARγ were investigated applying molecular docking as 
preliminary study in identifying potential candidate of 
antidiabetic drugs.  Rosiglitazone was choosen as a 
positive control. 
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Experimental 
Preparation of three-dimensional structure of target 
protein  
The three-dimensional structure of PPARγ (PDB ID 
2PRG) was obtained from Protein Data Bank, 
(http://www.rcsb.org/pdb). Macromolecular proteins 
were separated from the solvent and ligand or non-
standard residues. The separation of macromolecules 
from the unneeded molecules were performed using the 
Discovery Studio 3.5 Visualizer. Protein receptor that 
had been separated from the residues was optimized with 
Autodock Tools (ADT) v1.5.6. The optimization include: 
the addition of hydrogen atoms to macromolecule and 
setting the grid box parameters. The size of grid box was 
set at 28  28  28 (x,y,z) using 1.000 Å. The center of 
the grid box was put at 52.734  –3.774  34.258 (x,y,z).  
These results are saved in a format .pdbqt. 
 
Preparation of ligands 
Rosiglitazone (CID 77999) used as a standard and 
flavonoid compounds from Morindacitrifolia, including 
quercetin (CID 5280343), kaempferol (CID 5280863), 
rutin (CID 5280805), nicotifloroside (CID 5318767), and 
narcissoside (CID 5481663) were downloaded from 
Pubchem (http://PubChem.ncbi.nlm.nih.gov) with .sdf 
format. Ligands’ format were then converted into .pdb 
by using Open Babel. The structure of ligands that had 
been converted were further optimized with Autodock 
Tools by adding gasteiger charge. These results are 
saved in a format .pdbqt. MarvinSketch was used to 
perform QSAR studies in order to identify important 
molecular properties of ligands. Various properties of 
ligands such as logP, molecular weight, H bond donors, 
H bond acceptors were obtained. Lipinski’s Rule of Five 
was then applied to select probable ligands. 
 
 
 
 
Molecular Docking Analysis 
The docking analysis of citrus flavonoids were carried 
out by Autodock Vina program. Vina ran through the 
Command prompt. Vina configuration settings file was 
center_x = 52.734; center_y = –3.774; center_z = 34.258; 
size_x = 28; size_y = 28; size_z = 28, and 
exhaustiveness = 8. The results of docking calculations 
seen in the output were in notepad format. Determination 
of the conformation of the ligand docking results were 
done by selecting the ligand conformation that showed 
the lowest binding energy (best pose). The position and 
orientation of ligands in protein receptor and the 
interaction with amino acids that bound to the ligand 
were analyzed and visualized with AutoDock tools.  
 
Results and Discussion 
Docking results were ranked by ΔGbind best value 
(lowest energy). Low ΔGbind energy indicates that the 
conformation formed was stable, whereas high ΔGbind 
energy indicates that less stable complex was formed.  
 
Figure 2. 3D Structure of PPARγ. 
Kaempferol 
Narcissoside Nicotifloroside 
Quercetin 
Rutin Rosiglitazone 
Figure 1. Structure of ligands. 
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As shown in Table 1, flavonoids showed binding energy 
in the range –8.1 kcal/mol to 8.5 kcal/mol. Rutin 
produced the best value than other flavonoids. Even 
though, when compared with rosiglitazone, the value of 
the binding energy of flavonoids was still higher, but 
close to rosiglitazone (8.9 kcal/mol). This proves that 
flavonoids may show comparable potential with 
rosiglitazone as antidiabetic agent. 
 
Table 1 shows the protein residues that interact with the 
ligand. Hydrogen bond and hydrophobic contacts play an 
important role in the interaction between the ligands and 
the target protein. The best possible binding mode of all 
the ligands in target protein is displayed in Figure 3–8 by 
using AutoDock tools.   
 
The design aims to find drug molecule ligands that can 
interact effectively to the target receptor. But it does not 
mean that the compound will be active when given 
orally. On its way to the target, the drug will experience 
some of the events are called pharmacokinetics, 
including absorption, distribution, metabolism, and 
excretion (ADME). Pharmacokinetics should be 
considered in the design of new drugs. There will be no 
drug target interaction and hence no biological activity 
triggered by the drug when the drug molecule never 
reach the target. As an approach,   to design orally active 
drug, this drug must meet the 'Lipinski's Rule of Five’ 
which states that [7]: 
a) Its molecular weight should be less than 500. 
b) The compound's lipophilicity, expressed as logP 
should be less than 5. 
c) The number of groups as hydrogen bond donor 
should be less than 5. 
d) The number of groups as hydrogen bond acceptor 
should be less than 10. 
 
Applying this rule, five flavonoid compounds and 
rosiglitazone that had been docked on the target protein 
were further investigated using Marvinsketch software to 
determine whether these compounds meet the Rule of 
Five of Lipinski. The results were displayed in Table 2. 
The table shows that from five flavonoid compounds, 
only quercetin and kaempferol which meet the four 
criteria of 'Lipinski's Rule, while the other three 
compounds violent the rule. This means that only 
quercetin and kaemperol that may be systemically 
absorbed and hence bioavailable when orally 
administered. 
 
 
Table 1. ΔGbind values and ligand interaction with residues  
 
Ligand 
ΔGbind 
(kcal/mol) 
Hydrogen Bond Hydrophobic Contact 
Rosiglitazone 8.9 Ser289 
Leu228, Met329, Leu330, Leu333, Ile326, 
Arg288, Ala292, Cys285, Gln286, His449, 
Phe363 
Rutin 8.5 Cys285, Ser289 
Ala292, Glu291, Glu343, Ser342, Arg288, 
Leu330, Leu33 
Nicotifloroside 8.4 Glu291, Ser342 
Ala292, Cys285, Arg288, Glu343, Ile341, 
Ile326, Leu330, Leu333 
Narcissoside 8.3 Ser289, Glu343, Met348 
Tyr327, Phe363, Met364, Val339, Ile281, 
Leu330, Arg280,Ile341, Leu333, Ile326, 
Cys285,Gly284, Ser342, Arg288 
Quercetin 8.1 Ile326 Met329, Arg288, Ile341, Leu333 
Kaempferol 8.1 – 
Phe226, Met329, Leu330, Ile326, Arg288, 
Ala292 
 
 
Table 2. Lipinski’s Rule of Five from docked ligands 
 
Ligand Molecular Weight Log P H-Donor H-Acceptor 
Rosiglitazone 357,427 2.15 1 5 
Rutin 610,5175 0.87 10 16 
Nicotifloroside 594,5181 0.57 9 15 
Narcissoside 624,5441 0.72 9 16 
Quercetin 302,2357 2.16 5 7 
Kaempferol 286,2363 2.46 4 6 
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Figure 3. Visualization of Rosiglitazon interaction 
with residues. 
 
Figure 4. Visualization of Rutin interaction with 
residues. 
Figure 7. Visualization of nicotifloroside interaction 
with residues. 
Figure 8. Visualization of narcissosideinteraction with 
residues. 
Figure 5. Visualization of Quersetin interaction with 
residues. 
 
Figure 6. Visualization of Kaempferol interaction with 
residues. 
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Conclusions 
The docking result revealed that all the selected 
flavonoids showed binding energy ranging between –8.1 
kcal/mol to  –8.5 kcal/mol. Eventhough, when compared 
with rosiglitazone (–8.9 kcal/mol), the value of the 
binding energy of flavonoids was smaller, but close to 
rosiglitazone. This suggests that the flavonoid 
compounds have potency as antidiabetic agent. 
 
Based on Lipinski’s Rule, the five flavonoid compounds 
and rosiglitazone showed that from five flavonoid 
compounds, only quercetin and kaempferol which meets 
the four criteria of Lipinski’s Rule, while the other three 
are not. This means that only quercetin and kaemperol 
that may be clinically active when administered orally. 
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